{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/130254676"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "August 26 ??? Galectin Therapeutics, focusing on diseases such as fatty liver disease where galectin proteins play a major role in the disease process, has developed 2 classes of galectin inhibitors." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "hepb.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/436841424"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/130254676"] } } }
